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Bronchiolitis obliterans organizing pneumonia (BOOP) was described in 1985 as a distinct entity, with
different clinical, radiographic, and prognostic features than the airway disorder obliterative bron-
chiolitis and the interstitial ﬁbrotic lung disorder usual interstitial pneumonia/idiopathic pulmonary
ﬁbrosis.
The BOOP pattern may be idiopathic or may occur secondary to some of the following clinical
conditions: Idiopathic pulmonary ﬁbrosis, Wegener granulomatosis; at the wall of lung abscesses,
lymphomas, other neoplasms or after healing of infectious diseases. At these conditions, clinical
symptoms are primarily due underlying disorders.
We presented a case of BOOP mimicking a malignant disorder and occurring after Aspergillus infection
in a patient with chronic obstructive pulmonary disease.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Bronchiolitis obliterans organizing pneumonia (BOOP) is
a nonspeciﬁc response to various forms of lung injury and is the
pathological hallmark of the distinct clinical entity. It has been
classiﬁed as cryptogenic (idiopathic) or secondary.1 BOOP may
occur in association with connective tissue disease, with variable
immunodeﬁciency syndrome, HIV infection, hepatitis viral
infection, bacterial infections, graft vs. host disease and bone
marrow transplant, with lung transplant, drug toxicity, radiation
toxicity or it may be associated with lung tumours, ulcerative
colitis and myelodysplastic syndrome.2 We describe a unique case
in which developed BOOP associated with Aspergillus fumigatus
infection.2. Case
A 56-year-old man was admitted to our hospital, because of
a 2-week history of dyspnea and productive cough. His medicalaradurmus).
rved.history was remarkable for chronic obstructive pulmonary disease
(COPD) for three years. He smoked one-and-one-half packs of
cigarettes daily for 40 years. He had been receiving inhaled corti-
costeroid and a long-acting b2-agonist since the onset of COPDwith
improvement of his symptoms. The patient denied toxic gas inha-
lations, contact with animals, rashes, joint swelling, or diarrhea. He
did not have any connective-tissue disorder.
On admission, his body temperature was 36.8 C; respira-
tory rate was 17/min; blood pressure was 130/70 mm/Hg and
heart rate was 94 beats/min. On examination, no lymphade-
nopathy was found and dry crackles were audible over both
lung ﬁelds.
The haematocrit was 47% and the white cell count was
7200 cells/mm3 with 61% neutrophils, 38% lymphocytes and 1%
eosinophils. Levels of alanine aminotransferase, aspartate amino-
transferase, alkaline phosphatase, gamma-glutamyltransferase
and creatinine were normal, as were the results of coagulation.
The values determined in spirometric function test analyses were:
FEV1: 51%, FVC: 86%, FEV1/FVC: 66, PEF: 58%. Thorax tomography
(CT) has been performed because of determination of ﬁbrotic
alterations and atelectasia in right inferior zone by the lung
function test which was performed 1 year before admitting to our
hospital. In the CT results, an atelecticeﬁbrotic band reaching to
Fig. 1. a, b: An atelectic-ﬁbrotic band reaching to pleura from the hilus, panlobular
emphysema regions have been determined.
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lob and panlobular emphysema regions on both superior lobs have
been determined (Fig. 1a,b). Upon this, ﬂexible bronchoscopy has
been applied to the patient. Endobronchial lesion was not detected
by this intervention. Transbronchial biopsy could not be per-
formed because of the extensive emphysema which can lead to
pneumothorax and related risk of respiratory insufﬁciency. In
bronchoalveolary lavage, there was no ﬁnding demonstrating the
malignity. The mucosal biopsies have been reported as consisted
with chronic bronchiolitis. Then a transthoracic thin needle Biopsy
(TTTNB) was applied to the patient. TTTNB was at hypocellular
level, so alveolar macrophages and rare epithelial cells in normal
appearance were seen. After this application, pneumothorax
developed and tube thoracostomy was applied. Also a thora-
cotomy was applied to the patient for diagnosis. In the thora-
cotomy operation a 5  4,5  4,5 cm cuneiform lung tissue was
excised. Histopathological examination of the lung biopsy revealed
ﬁbroblastic plaques “Masson’s bodies” ﬁlling air spaces and
obstructing bronchioles in the lung paranchima (BOOP) (Fig. 2a)and a necrotic, inﬂammatory focus containing aspergillus coloni-
zation (aspergilloma) which branched organisms parallel to each
other and stained with Gomori’s methanamine silver (GMS)
(Fig. 2b and c).
In the light of these ﬁndings, the patient had been thought to
have a secondary BOOP occurred after A. fumigatus.
3. Discussion
Epler et al., in 1985, provided the ﬁrst description of BOOP as
a clinicopathologic entity.3,4 BOOP may be classiﬁed into three
categories according to its etiology: organizing pneumonia of
determined cause; organizing pneumonia of undetermined cause
but occurring in a speciﬁc and relevant context, and cryptogenic
(idiopathic) organizing pneumonia.1,5 BOOP is a distinct clinical
and pathologic entity characterized clinically by a ﬂu-like illness
with cough, crackles, and patchy peripheral inﬁltrates on chest
radiographs. This entity is deﬁned histopathologically as granu-
lation tissue plugs within the lumen of distal air spaces. The
pathogenesis involves damage of the bronchiolar epithelial cells
and recruitment of T lymphocytes and neutrophils to the site of
injury; many cytokines and chemokines are secreted, perpetu-
ating the inﬂammatory response and leading to ﬁbroblast
formation with obliteration of the airways.6,7 This process reﬂects
the response to an initial injury, which causes pulmonary
inﬂammatory/ﬁbrosing process involving the small airways that
often results in progressive, irreversible obstructive pulmonary
disease.7 Many cases are idiopathic, but BOOP may also be asso-
ciated with a wide range of different insults, connective tissue
disorders and infectious pneumonia. It is unusual to see the
pattern of BOOP following infection. However, infections due to
Nocardia asteroides, Serratia marcescens, Legionella pneumophila,
Mycoplasma pneumoniae, and Chlamydia pneumoniae have been
found associated with BOOP.8
Aspergillus spp. are airborne fungi that undergo a biphasic
growth process. Spores or conidia, which represent the form of
environmental persistence and dissemination, are inhaled during
breathing. Upper respiratory tract clearance of inhaled conidia is
facilitated by tracheobronchial ciliary activity. Conidia are inges-
ted and destroyed by airway macrophages that prevent germi-
nation to hyphal form. Pulmonary dendritic cells ingest both
conidia and hyphae, migrate to draining lymph nodes and
instruct the T helper-cell response.3,9 Human aspergillosis can be
classically divided as invasive, saprophytic or allergic. Inhalation
of airborne aspergillus spores results in colonization of the
respiratory mucosal surfaces.10 The combination of aspergilloma
and BOOP has never been reported in the English literature.
Testing for serum precipitins to A. fumigatus might be useful in
screening to determine which patients are at risk for developing
an aspergilloma.11
We had to apply thoracotomy, which is a quite invasive
method, to have a ﬁnal diagnosis for this patient. However, if it
will be in consideration that there can be BOOP in patients
with similar radiologic and clinic symptoms and Aspergillus
spp. can also lead to BOOP, one can diagnose the BOOP and
aspergillus without invasive treatments and can start the
therapy betimes.
We conclude that A. fumigatus itself is the suspected cause of
the disorder, though we have no direct proof. To our knowledge,
this is the ﬁrst case report indicating that A. fumigatus may
present as BOOP. Whether this association is merely coincidental
is subject to further investigation. Although we are aware of the
rarity of this presentation, we believe that A. fumigatus infection
should be added to the list of microorganisms capable of inducing
BOOP.
Fig. 2. a : Fibroplastic plaques in the lung (H&E, X100). b and c : Aspergillus colonization demonstrated with H&E and GMS stain (X200).
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